Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.


Journal

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors
ISSN: 1939-1501
Titre abrégé: Psychol Addict Behav
Pays: United States
ID NLM: 8802734

Informations de publication

Date de publication:
Mar 2019
Historique:
pubmed: 8 1 2019
medline: 18 12 2019
entrez: 8 1 2019
Statut: ppublish

Résumé

Smokers attempting to quit often attribute smoking relapse to negative affect, craving, and other nicotine withdrawal symptoms. In addition, there is evidence that smoking relapse can increase these symptoms, particularly negative affect. To address this issue, we analyzed data from an 11-week smoking cessation clinical trial in which smokers (n = 1,246) were randomized to receive either nicotine replacement therapy (NRT), varenicline, or placebo, combined with behavioral counseling. Using cross-lagged analyses, we examined the temporal bidirectional relationships between self-reported measures of affect, craving, and composite withdrawal symptoms and biochemically verified smoking abstinence. The relative strength of these temporal relationships was examined by comparing the explained variances of the models. The results showed that higher negative affect, craving, and composite withdrawal symptoms increased the likelihood of subsequent smoking relapse, and that smoking relapse led to subsequent increases in these same symptoms. A comparison of the explained variances found symptom predicting subsequent relapse models to be stronger than those where relapse predicted subsequent symptoms. Although the explained variance findings generally support a negative reinforcement conceptualization of nicotine dependence, the bidirectional relationship between symptoms and smoking relapse suggests that struggling with quitting smoking leads to significant negative affect, craving, and other withdrawal symptoms that do not quickly resolve. These findings highlight the importance of addressing specific symptoms within the context of smoking cessation. (PsycINFO Database Record (c) 2019 APA, all rights reserved).

Identifiants

pubmed: 30614717
pii: 2019-00277-001
doi: 10.1037/adb0000434
pmc: PMC6405298
mid: NIHMS997893
doi:

Substances chimiques

Smoking Cessation Agents 0
Varenicline W6HS99O8ZO

Banques de données

ClinicalTrials.gov
['NCT01314001']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

105-116

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NIDA NIH HHS
ID : U01 DA020830
Pays : United States
Organisme : National Institutes of Health
Organisme : MD Anderson's Cancer Center

Références

J Abnorm Psychol. 2015 Aug;124(3):623-34
pubmed: 25961814
J Abnorm Psychol. 2002 Nov;111(4):531-45
pubmed: 12428767
Prev Med. 1985 Mar;14(2):195-202
pubmed: 4048082
Nicotine Tob Res. 2004 Aug;6(4):599-614
pubmed: 15370156
Psychol Bull. 2003 Mar;129(2):270-304
pubmed: 12696841
Arch Gen Psychiatry. 1991 Jan;48(1):52-9
pubmed: 1984762
JAMA Psychiatry. 2013 May;70(5):522-33
pubmed: 23536105
Addict Behav. 2005 Mar;30(3):423-35
pubmed: 15718060
Nicotine Tob Res. 2003 Feb;5(1):13-25
pubmed: 12745503
Exp Clin Psychopharmacol. 2011 Feb;19(1):40-52
pubmed: 21341922
Annu Rev Psychol. 2008;59:29-53
pubmed: 18154498
J Consult Clin Psychol. 1987 Apr;55(2):145-9
pubmed: 3571666
Addiction. 2012 Aug;107(8):1501-11
pubmed: 22321019
Nicotine Tob Res. 2001 Feb;3(1):7-16
pubmed: 11260806
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
J Abnorm Psychol. 2012 Feb;121(1):187-97
pubmed: 21787035
Ann Behav Med. 1996 Sep;18(3):190-200
pubmed: 24203772
Nicotine Tob Res. 2012 Jan;14(1):75-8
pubmed: 22025545
Nicotine Tob Res. 2005 Aug;7(4):533-40
pubmed: 16085524
Exp Clin Psychopharmacol. 2012 Apr;20(2):139-50
pubmed: 22039752
Drug Alcohol Depend. 2007 Dec 1;91(2-3):159-68
pubmed: 17628353
Addiction. 2005 Aug;100(8):1074-89
pubmed: 16042638
Arch Gen Psychiatry. 1986 Mar;43(3):289-94
pubmed: 3954551
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Nicotine Tob Res. 2013 Jul;15(7):1167-82
pubmed: 23291636
Psychol Addict Behav. 2008 Mar;22(1):122-8
pubmed: 18298238
Br J Addict. 1991 Jan;86(1):57-69
pubmed: 2009399
J Abnorm Psychol. 2011 Nov;120(4):999-1005
pubmed: 21574668
J Consult Clin Psychol. 1996 Apr;64(2):366-79
pubmed: 8871421
Psychol Addict Behav. 2012 Sep;26(3):633-7
pubmed: 22352701
J Abnorm Psychol. 2009 May;118(2):348-59
pubmed: 19413409
Addict Behav. 1990;15(2):105-14
pubmed: 2343783
Psychopharmacology (Berl). 2011 Aug;216(4):569-78
pubmed: 21416234
J Abnorm Psychol. 2002 Nov;111(4):670-5
pubmed: 12428781
Health Psychol. 1991;10(5):343-51
pubmed: 1935870
J Abnorm Psychol. 2003 Feb;112(1):3-13
pubmed: 12653409
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
Prev Med. 1993 Mar;22(2):261-71
pubmed: 8483863
Psychol Rev. 2004 Jan;111(1):33-51
pubmed: 14756584
Addict Behav. 1990;15(3):235-45
pubmed: 2378283
J Consult Clin Psychol. 1982 Feb;50(1):71-86
pubmed: 7056922
Nebr Symp Motiv. 2009;55:171-97
pubmed: 19013944
Lancet Respir Med. 2015 Feb;3(2):131-138
pubmed: 25588294
J Consult Clin Psychol. 1997 Apr;65(2):292-300
pubmed: 9086693
J Abnorm Psychol. 2008 Aug;117(3):618-24
pubmed: 18729613
Addict Behav. 1988;13(3):253-66
pubmed: 3177069
Nicotine Tob Res. 2008 Jan;10(1):35-45
pubmed: 18188743
PLoS Med. 2010 Feb 09;7(2):e1000216
pubmed: 20161722
Drug Alcohol Depend. 2015 Mar 1;148:1-20
pubmed: 25637078
Addict Behav. 1986;11(1):49-53
pubmed: 3716916
J Consult Clin Psychol. 1990 Apr;58(2):175-81
pubmed: 2335634
J Consult Clin Psychol. 2002 Feb;70(1):216-27
pubmed: 11860048
Addict Behav. 1986;11(3):295-307
pubmed: 3739816

Auteurs

Jason D Robinson (JD)

Department of Behavioral Science.

Liang Li (L)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center.

Minxing Chen (M)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center.

Caryn Lerman (C)

Department of Psychiatry, Annenberg School for Communication, University of Pennsylvania.

Rachel F Tyndale (RF)

Centre for Addiction and Mental Health.

Robert A Schnoll (RA)

Department of Psychiatry, University of Pennsylvania.

Larry W Hawk (LW)

Department of Psychology, University at Buffalo, State University of New York.

Tony P George (TP)

Centre for Addiction and Mental Health, University of Toronto.

Neal L Benowitz (NL)

Department of Medicine, University of California, San Francisco.

Paul M Cinciripini (PM)

Department of Behavioral Science.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH